LT
Lotus Pharmaceuticals, Inc.
LTUS · OTC
$0.00 +0.00% (+$0.00)
1M -23.08%
Market Cap $85.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor ROA 331.14%
Asset turnover 0.00x
ROIC 330.99%
Debt
70 /100
Low Net debt/EBITDA -6.10x
Current ratio 0.05x
Int. coverage N/A
Stability
33 /100
Unstable Profitable years 0
Beta -1.60x
EPS volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre LTUS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Zhong Yi Liu
Employees
233
Headquarters
Irvine